Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III

Citation
S. Jablonka et al., Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III, HUM MOL GEN, 9(3), 2000, pp. 341-346
Citations number
23
Categorie Soggetti
Molecular Biology & Genetics
Journal title
HUMAN MOLECULAR GENETICS
ISSN journal
09646906 → ACNP
Volume
9
Issue
3
Year of publication
2000
Pages
341 - 346
Database
ISI
SICI code
0964-6906(20000212)9:3<341:RSMN(G>2.0.ZU;2-S
Abstract
Spinal muscular atrophy (SMA) is caused by deletion or specific mutations o f the telomeric survival motor neuron (SMN) gene on human chromosome 5. The human SMN gene, in contrast to the Smn gene in mouse, is duplicated and th e centromeric copy on chromosome 5 codes for transcripts which preferential ly lead to C-terminally truncated SMN protein. Here we show that a 46% redu ction of Smn protein levels in the spinal cord of Smn heterozygous mice lea ds to a marked loss of the cytoplasmic Smn pool and motor neuron degenerati on resembling spinal muscular atrophy type 3. Smn heterozygous mice describ ed here thus represent a model for the human disease. These mice could allo w screening for SMA therapies and help in gaining further understanding of the pathophysiological events leading to motor neuron degeneration in SMA.